BioSpace News Archive

Emergex Vaccines Holding Limited announced it has successfully completed the first step in the development of a candidate vaccine for the Gram-negative intracellular coccobacillus, Francisella tularensis.

New entity combines wholesale operations to drive sustainable growth and deliver efficient distribution solutions for an evolving market

TAILORx Study Featured in William L. McGuire Memorial Lecture Award at 2019 San Antonio Breast Cancer Symposium®

Health design and innovation studio GoInvo announced that Meghana Karande, MD will join as Medical Director for the firm.

Nordic Nanovector ASA reports an update on its LYMRIT 37-05 Phase 1 trial of Betalutin® in patients with relapsed/refractory diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation.

Assembly Biosciences, Inc. (Nasdaq: ASMB) (“Assembly”), today announced the pricing of an underwritten public offering of 5,151,515 shares of its common stock to the public at $16.50 per share

Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that it has entered into a feasibility evaluation with Genentech, a member of the Roche Group.

Lannett Company, Inc. (NYSE: LCI) today announced that it expects to commence marketing in the coming months a generic version of Adderall XR®, an extended-release mixed salt of a single entity Amphetamine tablet product (Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate), with strengths of 5 mg, 10 mg, 15 mg, 20 mg, 25 mg and 30 mg tablets

Entering into a new decade, boards and C-suite leaders around the globe are concerned with the escalating competition for specialized talent, their organizations’ culture and the ability to advance their digital maturity and embrace the transformative opportunities of technology.

Illnesses subsiding, FDA continues to aggressively investigate source and route of contamination to prevent future outbreaks